David C. Metz, M.D.
Professor of Medicine at the Hospital of the University of Pennsylvania
Co-director, GI Physiology laboratory
Director, Acid Peptic Disorders Specialty Program, Digestive and Liver Center
Associate Chief for Clinical Affairs, Division of Gastroenterology
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
3 Ravdin
3400 Spruce Street
Philadelphia, PA 19104
3 Ravdin
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-662-4279
Fax: 215-662-6530
Fax: 215-662-6530
Email:
david.metz@uphs.upenn.edu
david.metz@uphs.upenn.edu
Publications
Education:
M.D.
University of Witwatersrand, South Africa, 1982.
M.D.
University of Witwatersrand, South Africa, 1982.
Post-Graduate Training
Intern in Medicine and Surgery, Johannesburg General Hospital Witwatersrand University, Johannesburg, South Africa, 1983-1983.
Intern in Internal Medicine, Albert Einstein Medical Center, 1986-1988.
Fellowship in Gastroenterology, Georgetown VAMC-NIH Combined Program, 1989-1991.
Fellowship, NIH, NIDDK, Digestive Disease Branch, 1991-1993.
Permanent linkIntern in Medicine and Surgery, Johannesburg General Hospital Witwatersrand University, Johannesburg, South Africa, 1983-1983.
Intern in Internal Medicine, Albert Einstein Medical Center, 1986-1988.
Fellowship in Gastroenterology, Georgetown VAMC-NIH Combined Program, 1989-1991.
Fellowship, NIH, NIDDK, Digestive Disease Branch, 1991-1993.
Selected Publications
CT Lau, WB Gefter, DC Metz: Radiographic appearance of a catheter-free wireless esophageal pH probe. Am J Roentgenol 184: S40-42, 2005.GL Shih, C Brensinger, DA Katzka, DC Metz: Postprandial esophageal integrated acidity is a reliable predictor of GERD. Aliment Pharmacol Therap 21: 1475-1482, 2005.
DC Metz, PB Miner, DM Heuman, Y Chen, M Sostek: Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-esophageal reflux disease. Aliment Pharmacol Therap 22: 813-821, 2005.
Metz DC, Comer GM, Soffer E, Forsmark CE, Cryer B, Chey W, Pisegna JR: Three year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. Aliment Pharmacol Therap 23: 437-444, 2006.
Pratha V, Hogan DL, Lynn RB, Field B and Metz, DC: Intravenous Pantoprazole as Initial Treatment in Patients With Gastroesophageal Reflux Disease and a History of Erosive Esophagitis: A Randomized Clinical Trial. Dig Dis Sci 51: 1595-1601, 2006.
WC Blonski, GL Shih, CM Brensinger, DA Katzka, DC Metz. : Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms. Sc J Gastroenterol 41: 382-389, 2006.
Yang Y-X, Lewis JD, Epstein S, Metz DC: Chronic proton pump inhibitor therapy and hip fracture risk. JAMA 296: 1595-1601, 2006.
JD Lewis, BL Strom, SE Kimmel, J Farrar, DC Metz, C Brensinger, L Nessel, AR Localio: Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf 15: 39-45, 2006.
Howden C, Metz DC, Hunt B, Majid V, Kukulka M, Amer F, Samra N. : Dose-Response Evaluation of the Antisecretory Effect of Continuous Infusion Intravenous Lansoprazole Regimens over 48 Hours. Aliment Pharmacol Therap 23: 975-984, 2006.
Metz DC, Amer F, Hunt B, Majid V, Kukulka M. : Lansoprazole Regimens That Sustain Intragastric pH >6: An Evaluation of Intermittent Oral and Continuous IV Infusion Dosages. Aliment Pharmacol Therap 23: 985-995, 2006.
